Millions of dollars in a new state budget proposal could allow for the return of GLP-1 coverage for some state employees.

Pfizer decided to abort the clinical trial of its daily weight loss pill 'Danuglipron' after one patient in a trial showed signs of liver damage, likely to be caused by the drug.

Pfizer will end development of weight-loss pill over fears about its impact to the liver - The drugmaker said the patient’s injury ‘resolved’ after they stopped taking the drug ...

The rapid increase in the use of glucagon-like peptide-1 receptor agonists for weight loss, diabetes management and cardiovascular health has significant implications for orthopedic surgery.GLP-1 ...

What is 'Ozempic feet'? Side effect of the weight-loss drug revealed - Some people have reported they find standing or ...

GLP-1 agonists are a true black-swan event.

Nestle SA is launching GLP-1-friendly beverages under its Boost brand that contain a proprietary whey protein microgel technology, according to the company. Nestle said the innovation allows for more ...

Pfizer (NYSE: PFE) recently reminded investors how risky the drug-development business can be. On April 14, the company told investors it would scrap development of danuglipron, its oral GLP-1 ...

Medications like Ozempic, Wegovy, and Zepbound have helped many Americans lose weight, but there are still some misconceptions about these medications and metabolic health. Centre Spring MD founder ...

A recent review highlights the gaps in clinical guidelines and treatment approaches for metabolic dysfunction-associated steatohepatitis (MASH) and looks ahead to the future promise of glucagon-like ...

People who have tried other methods to lose weight have found results from obesity drugs that ‘feel like magic.’ ...

The FDA has issued a warning about counterfeit Ozempic injections circulating in the U.S., urging consumers to check labels and report adverse effects ...